🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized phase III trial studies 90-yttrium ibritumomab tiuxetan and...
Status
Terminated
Location
City of Hope Medical Center
Start Date
2015-01
Trial ID
NCT02366663
High-dose chemotherapy and autologous stem-cell transplantation have an est...
Status
Unknown
Location
Soroka Universuty Medical Center
Start Date
2007-04
Trial ID
NCT00463463
Treatments Being Tested
This is a European multicenter study of 90Yttrium-Ibritumomab Tiuxetan (90Y...
Status
Unknown
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT00772655
Treatments Being Tested
Monoclonal antibodies such as rituximab and yttrium Y 90 ibritumomab tiuxet...
Status
Terminated
Location
Northwestern University
Start Date
2003-10-28
Trial ID
NCT00089284
Treatments Being Tested
The study hypothesis is that the addition of zevalin radioimmunotherapy to ...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2007-06
Trial ID
NCT00491491
Treatments Being Tested